SCHEMBL29993252

SCHEMBL29993252

COc1cccc2[nH]cc(CCN([13CH3])[13CH3])c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 1.00
HTR2A P28223 9/20 0.69
HTR2C P28335 6/20 0.68
HTR2B P41595 6/20 0.68
HTR1A P08908 6/20 0.68
HTR1D P28221 2/20 0.65
HTR1B P28222 2/20 0.65
HTR1E P28566 2/20 0.65
HTR7 P34969 2/20 0.65
HTR5A P47898 2/20 0.65
DRD1 P21728 1/20 0.65
ADORA2A P29274 1/20 0.65
ADORA2B P29275 1/20 0.65
DRD3 P35462 1/20 0.65
MTNR1A P48039 2/20 0.59
MTNR1B P49286 2/20 0.59
SLC6A4 P31645 1/20 0.55
HTR1F P30939 2/20 0.51
HTR3E A5X5Y0 1/20 0.51
HTR3B O95264 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19235737 1.00 HTR6 (1.00) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL29758535 1.00 HTR6 (1.00) HTR6HTR2AHTR2CHTR2BHTR1A
Hydrochloric Acid SCHEMBL4208783 0.99 HTR6 (0.97) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL29992570 0.90 HTR6 (0.82) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL29992491 0.90 HTR6 (0.82) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL23069139 0.87 HTR6 (0.78) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL29968326 0.87 HTR6 (0.78) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL26965639 0.87 HTR6 (0.77) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL26289672 0.87 HTR6 (0.76) HTR6HTR2AHTR2CHTR2BHTR1A
SCHEMBL20970943 0.86 HTR6 (0.76) HTR6HTR2AHTR2CHTR2BHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240254081-A1 CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2024-08-01 US disclosed
EP-4334285-A1 CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS Kare Chemical Technologies Inc. (CA) 2024-03-13 EP disclosed
WO-2022232931-A1 CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2022-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240254081-A1 CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS HNMT, TPSB2, TPSG1 HTR6 45/4885HTR2A 33/4885HTR2C 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.